A Meta-Analysis of the Short- and Long-Term Results of Randomized Controlled Trials That Compared Laparoscopy-Assisted and Conventional Open Surgery for Colorectal Cancer by Ohtani, Hiroshi et al.
Journal of Cancer 2011, 2 
 
 
http://www.jcancer.org 
425 
J Jo ou ur rn na al l   o of f   C Ca an nc ce er r   
2011; 2: 425-434 
Research Paper 
A Meta-Analysis of the Short- and Long-Term Results of Randomized Con-
trolled Trials That Compared Laparoscopy-Assisted and Conventional Open 
Surgery for Colorectal Cancer 
Hiroshi Ohtani1, Yutaka Tamamori1, Yuichi Arimoto1, Yukio Nishiguchi2, Kiyoshi Maeda3, Kosei Hirakawa3  
1.  Department of Surgery, Osaka City Sumiyoshi Hospital 
2.  Department of Surgery, Osaka City General Hospital 
3.  Department of Surgical Oncology, Osaka City University Graduate School of Medicine 
 Corresponding author: Hiroshi Ohtani, Department of Surgery, Osaka City Sumiyoshi Hospital, 1-2-16, Higashi-Kagaya, 
Suminoe-ku, Osaka 559-0012, Japan. Tel: +81-6-6681-1000; FAX: +81-6-6686-1547; E-mail: m5051923@msic.med.osaka-cu.ac.jp 
© Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/ 
licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. 
Received: 2011.05.23; Accepted: 2011.07.28; Published: 2011.08.01 
Abstract 
Purpose:  We  conducted  a  meta-analysis  to  evaluate  and  compare  the  short-  and 
long-term results of laparoscopic colorectal surgery (LCRS) and conventional open sur-
gery (OCRS) for colorectal cancer (CRC). 
Methods: We searched relevant papers published between January 1990 and May 2011. 
We analyzed the outcomes of each type of surgery over the short- and long-term periods. 
Results: In the short-term period, we found no significant differences in overall periop-
erative complications and anastomotic leakage between LCRS and OCRS groups. We 
found  no  significant  differences  in  overall,  distant,  local  and  wound-site  recurrence, 
overall mortality, 3 and 5 year disease-free survival rate, and cancer-related mortality 
between the 2 groups. 
Conclusions:  LCRS  has  the  benefits  of  reducing  intraoperative  blood  loss,  earlier  re-
sumption of oral intake, and shorter duration of hospital stay in the short-term. The 
long-term outcomes of LCRS seem to be similar to those of OCRS. 
Key words: meta-analysis, laparoscopy-assisted colorectal surgery, colorectal cancer 
Introduction 
Colorectal  cancer  (CRC)  is  the  fourth  leading 
cause  of  cancer-specific  mortality  worldwide,  with 
610,000 related deaths each year1. CRC is the fourth 
most common form of cancer in the United States2 and 
the third leading cause of cancer-related death in the 
Western  world3.  Surgery  is  the  only  curative  treat-
ment for CRC. Laparoscopic resection for CRC was 
first described in 19914 and has since been widely ap-
plied by surgeons to treat patients with CRC.  
Several  articles  have  reported  the  short-term 
advantages of laparoscopic colorectal surgery (LCRS) 
over  conventional  open  colorectal  surgery  (OCRS) 
and have concluded that laparoscopic surgery causes 
less pain, results in better pulmonary function, shorter 
duration  of  postoperative  ileus,  less  fatigue,  and  a 
better quality of life5-7. However, the value of laparo-
scopic colorectal surgery has remained controversial 
because the long-term outcomes have not been clari-
fied. The long-term results of colorectal surgery, such 
as  tumor  recurrence  rate,  disease-free  survival  rate, 
and mortality rate, have been gradually published8-10. 
Several  randomized  control  trials  (RCTs)  that  com-
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pare  LCRS  with  OCRS  have  been  conducted8-30. 
Therefore, we conducted a meta-analysis of the data 
from these RCTs and compared the outcomes of LCRS 
and OCRS by considering several factors listed below. 
In addition, we selected the RCTs for which the fol-
low-up  period  was  at  least  3  years  to  evaluate  the 
long-term outcomes of LCRS.  
Materials and methods 
To  identify  papers  relevant  to  our  study  we 
searched through the major medical databases such as 
MEDLINE,  EMBASE,  Science  Citation  Index,  and 
Cochrane Controlled Trial Register for studies pub-
lished between January 1990 and May 2011. The fol-
lowing search terms were used: “laparoscopy,” “lap-
aroscopy-assisted,”  “surgery,”  “colorectal  cancer,” 
and all related articles. Furthermore, we limited our 
literature search to those studies that involved a fol-
low-up  period  of  3  or  more  years  to  examine  the 
long-term outcomes of LCRS. We treated studies that 
are part of a series or studies described by the same 
author as a single study. Most appropriate data of a 
series of studies were used for this meta-analysis.   
Three  researchers  (H.O.,  Y.T.,  and  K.H.)  ex-
tracted data from each article by using a structured 
sheet and entered the data into a database. Because 
this analysis was performed by the principle of inten-
tion-to-treat31, all patients converted from the laparo-
scopic group to the conventional open surgery group 
remained in the laparoscopic group for analysis. We 
conducted  a  meta-analysis  for  the  short-  and 
long-term. For the short-term analysis, we collected 
data on the duration of the operation, estimated blood 
loss, number of patients requiring transfusion, num-
ber of harvested lymph nodes, time required for re-
sumption  of  oral  intake,  duration  of  hospital  stay, 
length of operation wound, complications, and peri-
operative  mortality.  For  the  long-term  analysis,  we 
used data on the rate of tumor recurrence, disease-free 
survival  rate,  and  mortality.  If  necessary,  we  con-
tacted the authors  of the  original studies  to receive 
further information.  
Statistical analysis 
Weighted  mean  differences  (WMDs)  and  odds 
ratios (ORs) were used for the analysis of continuous 
and  dichotomous  variables,  respectively.  Ran-
dom-effects models were used to identify heteroge-
neity between the studies32 and the degree of hetero-
geneity was assessed using the χ2 test. The confidence 
interval (CI) was established at 95% and p values of 
less than 0.05 were considered to indicate statistical 
significance. Statistical analyses were performed us-
ing the Review Manager (RevMan) software version 
5.0.25 provided by the Cochrane Collaboration, Co-
penhagen, Denmark. 
Results 
We  identified  12  papers  reporting  RCTs  that 
compared  LCRS  and  OCRS  for  colorectal  cancer8-24. 
The characteristics of each RCT are presented in Table 
1. Our meta-analysis included 4458 patients with col-
orectal cancer; of these,  2375 had undergone LCRS, 
and  2083,  OCRS.  The  results  of  the  short-  and 
long-term are shown in Fig. 1 and Fig. 2, respectively. 
The outcomes of LCRS and OCRS in the short- and 
long-term are reported below. 
Short-term Outcomes 
The  operative  duration  for  LCRS  was  signifi-
cantly longer than for OCRS, i.e., by 39.32 min (WMD 
= 39.32; 95% CI = 30.72–47.91; p < 0.00001). Eleven of 
the 12 RCTs included data on operative duration, and 
the 11 RCTs indicated that the duration of operations 
using LCRS was significantly longer than that of op-
erations using OCRS. Blood loss in patients who un-
derwent LCRS was significantly lesser than patients 
in those who underwent OCRS, by an average volume 
of  133.05  ml  (WMD  =  -133.05;  95%  CI  =  -201.30  to 
-64.81;  p  =  0.0001).  We  found  no  significant  differ-
ences  between  patients  who  underwent  LCRS  and 
those  that  had  OCRS  for  the  number  of  transfused 
patients  or  the  number  of  dissected  lymph  nodes. 
Patients in the LCRS group resumed oral intake on an 
average of 1.08 days sooner than did patients in the 
OCRS  group,  and  the  difference  was  significant 
(WMD = -1.08; 95% CI = -1.36 to -0.80; p < 0.00001). 
The duration of hospital stay was significantly shorter 
by an average of 2.80 days for patients in the LCRS 
group  than  for  those  in  the  OCRS  group  (WMD  = 
-2.80; 95% CI = -4.78 to -0.81; p = 0.006). The average 
length of the wound caused by each operation was 
significantly shorter by 10.97 cm in the LCRS group 
than in the OCRS group (WMD = -10.97; 95% CI = 
-14.37  to  -7.57;  p  <  0.00001).  Differences  in  overall 
perioperative complications and anastomotic leakage 
between the LCRS group and the OCRS group were 
insignificant for treatment of the colorectal cancer. We 
also found no significant differences in perioperative 
mortality  between  the  surgery  groups  when  we 
pooled data for treatment of the colorectal cancer.  
Long-term Outcomes 
The rate of wound-site recurrence for patients in 
the  LCRS  group  was  significantly  higher  than  for 
those in the OCRS group in our analysis of the pooled 
data  for  CRC  treatment  (OR  =  2.87;  95%  CI  = 
1.08–7.68; p = 0.04). Restricting wound-recurrence to  Journal of Cancer 2011, 2 
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isolated abdominal-wall recurrences, in the absence of 
recurrent disease elsewhere, the differences between 
the groups was insignificant (p = 0.09). Our analysis of 
the local and distant metastasis recurrence between 
the LCRS group and the OCRS group for treatment of 
the  colorectal  cancer  indicated  no  significant  differ-
ence. There was also no significant difference between 
the surgery groups for the overall recurrence of tu-
mors. 
We found no significant differences in the 3- and 
5-year  disease-free  survival  rates  between  patients 
who  underwent  LCRS  and  those  who  underwent 
OCRS. 
There was no significant difference between the 
LCRS and OCRS groups for cancer-related mortality 
for treatment of the colorectal cancer. Likewise, there 
was no significant difference in overall mortality be-
tween the LCRS and OCRS groups. 
Heterogeneity 
In the short-term period, significant heterogene-
ity was detected between studies with respect to the 
following  4  factors:  intraoperative  blood  loss,  dura-
tion of hospital stay, length of operation wound, and 
overall  complications.  In  the  long-term  period,  no 
significant heterogeneity was detected between stud-
ies. 
Table 1. Characteristics of the randomized clinical trials 
authors  Year  number of ref-
erence 
institutions of 
the study 
Study size (n)  lesional site  follow-up period 
(months) 
          LCRS  OCRS       
Araujo et al.  2003  11  single center  13  15  rectum  47.2 months (mean) 
Braga at al. (colon)  2010  12  single center  134  134  colon  73 months (median) 
Braga at al. (rec-
tum) 
2007  13  single center  83  85  rectum  53.6 months (mean)/ 
54.2 months (median) 
CLASICC  2010, 2007, 
2005 
8,9,16  multicenter   526  268  colon or rectum  56.3 months (median) 
COLOR  2009, 2005  17,18  multicenter   534  542  colon  53 months (median) 
COST  2004  19  multicenter  435  428  colon  4.4 years (median) 
Curet et al.  2000  20  single center  25  18  colon  4.9 years (mean) 
Lacy  2002  10  single center  111  108  colon  43 months (median) 
Leung   2004  21  2 centers   167  170  colon or rectum  51 months (median) 
Liang  2006  22  single center  135  134  colon  40 months (median) 
Mirza et al.  2008  23  single center  116  117  colon or rectum  48 months (median) 
Park et al.  2009  24  single center  170  374  rectum  36 months (mean) 
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Fig. 2 Meta-analysis of the long- term period for colorectal cancer 
 
Discussion 
Previous articles showed that laparoscopic sur-
gery for CRC is associated with low morbidity, less 
pain, fast recovery, and short hospital stay, compared 
to  conventional  open  surgery  in  the  short-term5-7. 
Recent  articles  reporting  RCTs  have  shown  that 
long-term oncological results for LCRS are compara-
ble to those for OCRS33. There are claims that LCRS 
prolongs  cancer-related  survival10.  Therefore,  we 
examined the oncological results of LCRS and com-
pared to those of OCRS in short- and long-term peri-
ods by a meta-analysis of 12 RCTs.  
In  the  short-term  period,  this  meta-analysis 
showed that LCRS has a significantly long operative 
time  but  significantly  reduces  the  intraoperative 
blood  loss  compared  with  OCRS.  These  results  are 
consistent with those of the recent RCTs10, 22. Potential 
explanations for the abovementioned results are me-
ticulous dissection facilitated by instruments for lap-
aroscopic  surgery  and  videoscopic  magnification34. 
We also found that there was no significant difference 
in the number of patients requiring blood transfusions 
between the LCRS and OCRS groups. The lack of dif-
ference in the number of harvested lymph nodes be-
tween the 2 groups may suggest that the quality of the 
operative  techniques  is  the  same.  Patients  who  un-
derwent LCRS resumed oral intake significantly ear-
lier and had significantly shorter hospital stays than 
did patients who underwent OCRS; this finding sug-
gests that LCRS leads to faster recovery. The safety 
and feasibility of LCRS is similar to that of OCRS as 
shown  by  insignificant  differences  in  the  overall 
perioperative  complications,  anastomotic  leakage, 
and  perioperative  mortality  between  the  surgery 
groups. 
In the long-term period, this study showed that 
there is no significant difference in the overall recur-
rence, local recurrence, or distant recurrence of me-
tastases  between  the  LCRS  and  OCRS  groups.  The 
rate of wound-site recurrence for the LCRS group was 
significantly higher than that for the OCRS group. In 7 
of the 9 studies that reported data on wound-site re-
currence, the rates of wound-site recurrence for LCRS 
were similar to the rates for OCRS. In the CLASICC 
trial,  the  number  of  extraction-site  recurrences  was 
higher than that of trocar-site recurrences in the LCRS 
group. Therefore, the authors emphasize the need for 
adequate wound protection during specimen extrac-
tion13. In the COLOR trial, the number of trocar-site 
recurrences  was  higher  than  that  of  extraction-site 
recurrences in the LCRS group. In this meta-analysis 
the differences of wound-site recurrence between the 
groups  was  insignificant,  restricting 
wound-recurrence to isolated abdominal-wall recur-
rences, in the absence of recurrent disease elsewhere. 
Lim et al. reported that port-site metastasis may be a 
part of the systemic disease rather than an unfortu-
nate sequelae of the learning curve for laparoscopic 
surgery35.  
We found no significant difference between the 
LCRS and OCRS groups for overall mortality, 3- and 
5-year  disease-free  survival  rate  and  cancer-related 
mortality.  These  results  suggest  that  the  long-term 
oncological  results  of  LCRS  are  similar  to  those  of 
OCRS.  Lacy  et  al.  reported  that  LCRS  significantly 
prolongs cancer-related survival in treatment of colon 
cancer10, but our meta-analysis of the pooled data did 
not show this difference. 
Quality of life (QOL) after laparoscopic surgery 
is improved in the early  postoperative period com-
pared with QOL after open surgery. In the long-term 
period, however, QOL after LCRS is similar to QOL 
after OCRS9, 36. From the cosmetic viewpoint, LCRS is 
superior  to  OCRS  because  the  length  of  operation  Journal of Cancer 2011, 2 
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wound  was  significantly  shorter  in  LCRS  than  in 
OCRS. 
Significant heterogeneity was observed between 
the 12 RCTs for intraoperative blood loss, duration of 
hospital  stay,  length  of  operation  wound,  overall 
complications  in  the  short-term  period,  and  overall 
mortality in the long-term period. This heterogeneity 
may  be  attributable  to  variation  in  the  skills  of  the 
surgeons and the condition of the tumor. 
In  conclusion,  this  meta-analysis  showed  that 
LCRS  has  the  benefits  of  reducing  intraoperative 
blood  loss,  earlier  resumption  of  oral  intake,  and 
shorter  duration  of  hospital  stay  in  short-term  and 
seems to be similar in the long-term oncological out-
comes, comparing to OCRS. Therefore LCRS may be 
an acceptable treatment as OCRS for CRC. 
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